Summary

Overview
The global anesthesia ultrasound systems market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031.
Ultrasound is a safe, portable, relatively inexpensive, and easily accessible imaging modality, making it a useful diagnostic and monitoring tool in medicine. Anesthesiologists encounter a variety of emergent situations and may benefit from the application of such a rapid and accurate diagnostic tool in their routine practice.
The current and potential applications of ultrasound in anesthesiology encourage anesthesiologists to learn and use this useful tool as an adjunct to physical examination. Ultrasound-guided peripheral nerve blockade and vascular access represent the most popular ultrasound applications in anesthesiology.
Ultrasound-guided peripheral nerve blockade is perhaps the most popular ultrasound application used by anesthesiologists. It might be the gold standard for regional anesthesia, it allows anesthesiologists to perform regional anesthesia more accurately and it expands the ability to block smaller nerves and those in more difficult anatomic locations.
Anesthesiologists and nurse anesthetists are increasingly using ultrasound-guided needle placement to improve operating efficiency while decreasing placement complications and patient discomfort. Medical research supports the use of ultrasound in anesthesia-related needled placements.
Market Dynamics: Drivers
Increasing adoption of anesthesia ultrasound systems for pain management
The demand for the anesthesia ultrasound systems market is driven by multiple factors. One of the key factors is the increasing adoption of anesthesia ultrasound systems for pain management is expected to drive the market over the forecast period. The use of ultrasound in pain management procedures allows healthcare professionals to precisely target specific nerves or areas, leading to more effective pain relief.
National Institute of Health (NIH), stated that the use of ultrasound has been shown to have 100% accuracy in locating the caudal space and guiding epidural needles for caudal injections for low back pain. Ultrasound has been shown to offer excellent guidance in selective ganglion or nerve blocks for invasive pain therapy. Lumber sympathetic and celiac plexus have been shown to yield similarly good results with ultrasound imaging as with computed tomography scans. A new ultrasound-based approach to facet nerve block under guidance is simpler and avoids radiation.
Anesthesia ultrasound systems enable practitioners to visualize the targeted area in real time by facilitating the accurate placement of needles for nerve blocks or other pain management procedures. The use of ultrasound guidance in pain management can contribute to improved patient comfort. By accurately locating the source of pain and administering interventions with precision, healthcare providers can potentially reduce the need for multiple attempts and minimize discomfort for the patient.
For instance, on October 20, 2022, Intelligent Ultrasound (IU) stated that it had added even more functionality to its ScanNav Anatomy Peripheral Nerve Block (PNB) platform and widened its availability to support regional anesthesia. Designed to help qualified healthcare professionals perform ultrasound-guided regional anesthesia safely, ScanNav Anatomy PNB enhances the accuracy and standardization of ultrasound image interpretation.
In addition, developed with leading experts in anesthesiology, ScanNav Anatomy PNB uses next-generation AI algorithms to highlight structures relevant to regional anesthesia during a live ultrasound scan. 3D reference material provides an overview of the relevant anatomy and probe positioning and demonstrates virtual scanning for the selected anatomical region.
Anesthesia ultrasound systems have been increasingly utilized in chronic pain management, including procedures such as epidural injections, nerve blocks, and joint injections. The ability to visualize structures in real time allows for a more targeted and personalized approach to pain relief. The increasing demand for minimally invasive procedures is also driving the adoption of anesthesia ultrasound systems. These systems facilitate efficient and effective pain management interventions that can be performed in ambulatory settings, reducing the need for hospitalization.
Moreover, key players in the market launch new products to propel the market growth. For instance, in April 2022, the introduction of the Rafa Tuohy needle with enhanced visualization and user-friendly features could potentially strengthen Vygon's position in the anesthesia ultrasound system market, offering improved accuracy and efficiency in epidural anesthesia under ultrasound guidance.
Also, in September 2022, The MSK Ultrasound Machine by Chison Medical is a non-invasive musculoskeletal imaging device that provides high-resolution images of joints, tendons, and muscles, aiding in diagnosing and treating various musculoskeletal conditions, including inflammatory conditions causing muscle pain in adults.
Further, the increasing demand to screen for and identify deep venous thrombosis (DVT) that could form into a pulmonary embolism, increasing awareness about the advantages of these systems, and increasing technological advancements are expected to drive the market over the forecast period.
Restraints
Factors such as complications associated with these ultrasound systems, high costs associated with the anesthesia ultrasound systems, regulatory compliance, stringent approval process, concerns related to data security and privacy issues, and ultrasound techniques requiring improved anatomical knowledge are expected to hamper the market.
For more details on this report - Request for Sample
Segment Analysis
The anesthesia ultrasound systems market is segmented based on system type, application, end-user and region.
The point-of-care ultrasound segment accounted for approximately 65.3% of the anesthesia ultrasound systems market share
The point-of-care ultrasound segment is expected to hold the largest market share over the forecast period. Point-of-care ultrasound (POCUS) systems have gained popularity and are commonly used in various medical settings due to their wide-ranging advantages. Providing in-depth visualization, these systems enable accurate nerve blocks, allowing for better navigation of needle-guided procedures and resulting in more effective patient monitoring.
One of the primary advantages of point-of-care ultrasound systems is its ability to provide real-time imaging. Healthcare professionals can immediately visualize anatomical structures and assess physiological functions, aiding in prompt decision-making and patient management. POCUS allows for rapid diagnostic assessments, which is particularly valuable in emergency and critical care settings. Some point-of-care anesthesia ultrasound systems are also aided by artificial intelligence technology to provide real-time guidance.
For instance, on October 06, 2023, GE HealthCare launched its Venue Family point-of-care ultrasound systems with feature Caption Guidance, artificial intelligence (AI)-driven technology that provides real-time guidance to users for capturing diagnostic-quality cardiac images. Caption Guidance is an optional add-on that offers new capabilities at the point of care, supporting clinicians in a wide range of clinical settings and practices such as emergency departments, critical care wards, and anesthesiology.
Ultrasound-guided nerve block is among the most common uses of POCUS in anesthesiology. There are many diverse use cases for POCUS in anesthesiology, and a growing body of research shows that it boosts efficiency, improves patient outcomes, and enriches the quality of care. POCUS is also a fast and accurate way to detect pneumothorax, pleural effusions, and consolidation in critical patients instead of relying solely on chest auscultation or chest radiograph. Proficiency with POCUS also enables ultrasound-guided regional anesthesia, which can improve patient outcomes with perioperative pain management and postoperative recovery.
Also, in January 2023, FUJIFILM Sonosite, Inc., specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the larger Fujifilm Healthcare portfolio, announced the launch of the new Sonosite PX ultrasound system. Sonosite PX is the next generation in Sonosite POCUS, with the most advanced image clarity ever seen in a Sonosite system, a suite of workflow efficiency features, and an adaptable form factor.
Geographical Analysis
North America accounted for approximately 42.3% of the anesthesia ultrasound systems market share
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing advancements. North America especially the United States is very well-known for its strong presence of major players such as pharmaceutical and medical device companies. The presence of major market players in the region always focuses on developing technologically advanced anesthesia ultrasound systems such as anesthesia ultrasound systems with artificial intelligence technology.
The healthcare sector in North America is known for its early adoption of new technologies and innovations. The region often experiences a high rate of technological advancements in ultrasound systems. This continuous innovation can drive market growth as healthcare providers seek to incorporate the latest technologies into their practices. Thus, the above-mentioned factors are expected to drive the market in the region.
For instance, on August 14, 2023, Alpinion Medical Systems Co. Ltd. launched the X-Cube i9, a portable ultrasound device with dual batteries and probe connectors. It sets up in just one minute and offers extended portability, providing up to 100 hours of standby mode and more than one hour of scan mode operation. The Needle Vision Plus, which clearly shows the injection needle's location in real-time, increased accuracy and stability during ultrasound-guided anesthesia and nerve block and improved diagnosis efficiency through post-processing support after storage.
Also, in March 2022, Onvision Needle Tip Tracking, a new ultrasound-based technology from Braun Melsungen AG for peripheral nerve blocks, enables accurate needle tip recognition in real-time, making it useful for both beginning and experienced practitioners.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the global anesthesia ultrasound systems market. Regional anesthesia is often preferred over general anesthesia for COVID-19 patients. Avoidance of general anesthesia reduces the need for aerosol-generating procedures. Administration of ultrasound-guided regional anesthesia and surgery under regional anesthesia in COVID-19 patients requires careful infectious precautions to prevent viral spread through the use of equipment. During the pandemic, there is a temporary disruption of the supply chain of these systems.
Market Segmentation
By System type
- Portable
- Ultra-Portable
- Point-of-care
By Application
- Peripheral Nerve Block
- Supraclavicular Block
- Interscalene Block
- Infraclavicular Block
- Femoral Nerve Block
- Others
By End-Users
- Hospitals
- Specialized Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
Competitive Landscape
The major global players in the anesthesia ultrasound systems market include Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., BK Medical Holding Company, Inc., Koninklijke Philips N.V., FUJIFILM India Private Limited, Clarius, GE HealthCare, Intelligent Ultrasound, Trivitron Healthcare and TELEMED, UAB among others.
Key Developments
- On September 11, 2023, Intelligent Ultrasound Group plc the ‘classroom to clinic’ ultrasound company, specializing in artificial intelligence (AI) software and simulation, announced that GE Healthcare has launched SonoLyst live onto its latest version of the Voluson Expert Series portfolio of ultrasound machines.
- On June 20, 2023, Medovate Ltd, a company that creates medical equipment, and 20/20 Imaging signed a distribution agreement to make its SAFIRA regional anesthetic technology available in the United States. Ultrasound-guided regional anesthesia and Konica Minolta Healthcare Americas ultrasound technologies are the main topics of the partnership.
- On September 2, 2022, Intelligent Ultrasound (IU) announced that it has launched an updated version of its ‘first in kind’ technology Needle Trainer, making ultrasound-guided needle training even more accessible to medical professionals, through a high-performance, pocket-sized wireless ultrasound machine.
Why Purchase the Report?
- To visualize the anesthesia ultrasound systems market segmentation based on system type, application, end-user, region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development
- Excel data sheet with numerous data points of anesthesia ultrasound systems’ market level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- System type mapping is available in excel consisting of key system types of all the major players.
The anesthesia ultrasound systems market report would provide approximately 62 tables, 56 figures, and 185 Pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by System type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Adoption for Pain Management
4.1.2. Restraints
4.1.2.1. High Cost Associated with the Anesthesia Ultrasound Systems
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By System type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By System type
7.1.2. Market Attractiveness Index, By System Type
7.2. Portable*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ultra-Portable
7.4. Point-of-Care
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Peripheral Nerve Block *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Supraclavicular Block
8.4. Interscalene Block
8.5. Infraclavicular Block
8.6. Femoral Nerve Block
8.7. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialized Clinics
9.4. Ambulatory Surgical Centers
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By System type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By System type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By System type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By System type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.5.1. China
10.5.5.2. India
10.5.5.3. Japan
10.5.5.4. South Korea
10.5.5.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By System type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Siemens Healthineers AG
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
12.3. Koninklijke Philips N.V.
12.4. FUJIFILM India Private Limited
12.5. Clarius
12.6. GE HealthCare
12.7. Intelligent Ultrasound
12.8. BK Medical Holding Company, Inc
12.9. Trivitrion Healthcare
12.10. TELEMED, UAB
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us